INTRODUCTION
============

The most common primary lymphoma of the gastrointestinal (GI) tract is mucosa-associated lymphoid tissue (MALT) lymphoma.[@B1] Although 90% of gastric MALT lymphomas are related to the presence of *Helicobacter pylori*,[@B2] areas other than the GI tract may be affected. We describe here a patient with gastric MALT lymphoma that metastasized to the mediastinal lymph node (LN) and regressed following *H. pylori* eradication.

CASE REPORT
===========

A 66-year-old female presented with a 1-month history of dyspepsia. An initial upper GI endoscopy showed a shallow ulcerative lesion in the gastric high body and a hyperemic lesion in the low body ([Fig. 1A](#F1){ref-type="fig"}). A rapid urease test was positive for *H. pylori*. Histologic sections of the high and low bodies showed patchy infiltration of small lymphocytes into the lamina propria and lymphoepithelial lesions; the lymphocytes were focally aggressive toward the gland ([Fig. 1B](#F1){ref-type="fig"}). Phenotypic analysis showed that the lesion was positive for CD20, but negative for CD3, CD5, CD10, and Bcl-6, and that its proliferation rate was \<2%, as shown by MIB1 (Ki-67) antibody analysis. Based on these histopathological and phenotypic features, the patient was diagnosed with low-grade MALT lymphoma. Staging procedures were performed. Endoscopic ultrasound (EUS) revealed hypoechoic disruption of the mucosal and submucosal layers; moreover, the fourth layer was preserved and there was no evidence of locoregional lymphadenopathy (u-T1smN0) ([Fig. 1C](#F1){ref-type="fig"}). A computed tomography (CT) scan showed a huge LN, about 30×15 mm in size, in the subcarinal area ([Fig. 1D](#F1){ref-type="fig"}). Fusion whole body positron emission tomography (PET) showed a hypermetabolic lesion, suggestive of a malignant lesion, on the subcarinal area. ([Fig. 1E](#F1){ref-type="fig"}). Bone marrow biopsy findings were normal. EUS of the subcarinal lesion showed 32×12 mm LN. Histopathological and phenotypic analysis of a biopsy sample obtained by EUS-guided fine needle aspiration ([Fig. 1F](#F1){ref-type="fig"}) showed that the lesion was a MALT lymphoma ([Fig. 1G](#F1){ref-type="fig"}). The patient was diagnosed with a stage 4E gastric MALT lymphoma. For *H. pylori* eradication, the patient was treated with a 14-day course of amoxicillin 2,000 mg a day, clarithromycin 1,000 mg a day and pantoprazole 80 mg a day.

An endoscopy performed 2 months after treatment showed that the gastric high and low bodies were pale and flat, with no evidence of lymphoma infiltration ([Fig. 2A and C](#F2){ref-type="fig"}). EUS of the subcarinal area and CT showed that the LN had decreased markedly in size, to 12×11 mm ([Fig. 2E and G](#F2){ref-type="fig"}). Follow-up PET showed no significantly abnormal hypermetabolic lesions ([Fig. 2I](#F2){ref-type="fig"}).

One year after treatment, all assessments, including endoscopy with biopsy, CT, PET, and EUS, showed normal results ([Fig. 2B, D, F, H and J](#F2){ref-type="fig"}). At present, 14 months later, the patient remains in complete remission.

DISCUSSION
==========

More than 90% of gastric lymphomas are related to the presence of *H. pylori*; hence, eradication of *H. pylori* is the favored initial treatment for patients with early-stage *H. pylori*-positive gastric MALT lymphoma.[@B2]

However, the association between extragastric MALT lymphoma and *H. pylori* is not clear. Although several case reports have described the regression of extragastric MALT lymphomas after *H. pylori* eradication,[@B3],[@B4] one study showed that the majority of patients with extragastric MALT lymphoma did not benefit from *H. pylori* eradication.[@B5]

In addition, there have been a few case reports showing that *H. pylori* eradication has led to the regression of advanced gastric MALT lymphomas simultaneously involving two or more organs other than the stomach.[@B6],[@B7] Recirculation of *H. pylori* - specific T-cells from the stomach to other organs via the blood or lymphatic system may trigger an inflammatory response in other MALT-lymphoma containing organs.[@B3],[@B4],[@B6],[@B7] Alternatively, abnormal cells may spread from the stomach to other organs via the blood or lymphatic system.[@B5],[@B8]

*H. pylori* eradication may also lead to the regression of secondarily involved perigastric LN and bone marrow. However, our patient was different, in that *H. pylori* eradication led to the regression of a mediastinal LN.

The treatment for advanced gastric MALT lymphoma has not been clearly defined. Treatment is usually similar to that for patients with other advanced-stage indolent non-Hodgkin lymphoma.[@B9] Our findings, however, indicate that *H. pylori* eradication should be the first treatment in patients presenting with *H. pylori*-associated advanced gastric MALT lymphoma. Further molecular characterization of these tumors is necessary to determine the most suitable therapeutic strategy.
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![Initial diagnostic tests. (A) Initial upper gastrointestinal endoscopy displaying a shallow ulcerative lesion in the gastric high body and a hyperemic lesion in the gastric low body. (B) Histopathologic examination of a gastric biopsy specimen displaying patchy infiltration of small lymphocytes and lymphoepithelial lesions in the lamina propria, which suggest the existence of a mucosa-associated lymphoid tissue (MALT) lymphoma (H&E stain, ×400). (C) Endoscopic ultrasound (EUS) analysis displaying hypoechoic disruption of the mucosal and submucosal layers. (D) Computed tomography scan displaying a 30×15 mm lymph node (LN) in the subcarinal area. (E) Positron emission tomography analysis displaying a hypermetabolic lesion suggestive of a malignant lesion in the subcarinal area. (F) EUS analysis of the subcarinal lesion revealing a 32×12 mm LN. (G) Histopathologic examination of LN tissue, with the patchy infiltration of small lymphocytes, suggesting a MALT lymphoma (H&E stain, ×400).](gnl-6-270-g001){#F1}

![Follow-up evaluations 2 months (A, C, E, G, I) and 1 year (B, D, F, H, J) after *Helicobacter pylori* eradication. (A, C) Upper gastrointestinal endoscopy, displaying pale, flat gastric high and low bodies without lymphoma infiltration (H&E stain, ×400). (E, G) Endoscopic ultrasound and computed tomography scans of the subcarinal area, displaying a markedly smaller lymph node, sized 12×11 mm. (I) Positron emission tomography analysis displaying no significantly abnormal hypermetabolic lesions. (B, D, F, H, J) All findings were unremarkable.](gnl-6-270-g002){#F2}
